Recital 10, Regulation (EU) 2025/117

In forcesince 24 Jan 2025

Requesting expert panel consultation and joint scientific consultation on the clinical development plans is a new process for health technology developers of medical devices and in vitro diagnostic medical devices. Therefore, the health technology developers should be able to get assistance for the preparation of a timely and quality briefing package from the assessor and co-assessor for joint scientific consultation appointed pursuant to Article 18(3) of Regulation (EU) 2021/2282 (‘the assessor and co-assessor’) and from the staff members of the HTA secretariat responsible for providing secretariat support to the JSC Subgroup.